Glucuronic acid is a novel source of pentosidine, associated with schizophrenia
Kazuya Toriumi(Tokyo Metropolitan Institute of Medical Science), Makoto Arai(Tokyo Metropolitan Institute of Medical Science), Masanari Itokawa(Fujita Health University), Syudo Yamasaki(The University of Tokyo), Kazuhiro Suzuki(National Institute of Health Sciences), Mitsuhiro Miyashita(Tokyo Metropolitan Institute of Medical Science), Ryoji Nagai(Kyushu Tokai University), Kyoka Iino(Tokyo Metropolitan Matsuzawa Hospital), Satoshi Yamaguchi(Tokyo Metropolitan Institute of Medical Science), Hidenori Kamiguchi(Takeda (Japan)), Koichi Tabata(Tokyo Medical and Dental University), Azuna Ozawa(Tokyo Metropolitan Matsuzawa Hospital), Hikari Sugawa(Kyushu Tokai University), Atsushi Nishida(Tokyo Institute of Psychiatry), Satoshi Usami(Japan Graduate School of Education University)
Cited by 9
Related Papers
Improving polygenic prediction in ancestrally diverse populations
|Nature Genetics|2022|714
Structure of pathological TDP-43 filaments from ALS with FTLD
|Nature|2021|326
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
|Cell Reports|2018|264
Brain Cannabinoid CB2 Receptor in Schizophrenia
|Biological Psychiatry|2009|184
Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia
|Archives of General Psychiatry|2010|166